Anxiety prevalence research
Generalized anxiety disorder is documented at higher rates in women. Selank's clinical research originated in mixed-sex cohorts evaluated for anxiolytic endpoints.
Recovery
Selank
Stress & cognition
A synthetic heptapeptide analog of tuftsin studied for anxiolytic and nootropic activity in pre-clinical and limited clinical models.
$39.99per vial · research use
Quantity
Up to 50%
- GABA modulation studies
- BDNF research
- Cognitive performance models
For research use only. Not for human consumption.
Women's research notes
What researchers study Selank for in women
Selank research is referenced in women's stress and anxiety studies — a research area with documented sex-based prevalence (anxiety disorders are roughly twice as common in women).
Cognitive performance under stress
Pre-clinical female models have examined working-memory endpoints under stress conditions.
BDNF & neuroplasticity
Sex-based differences in BDNF expression are documented. Selank research has measured BDNF in female pre-clinical models.
Selected literature
- Medvedev VE, et al. Zh Nevrol Psikhiatr 2014 — Selank in anxiety disorders
- Kost NV, et al. Bull Exp Biol Med 2016 — Selank and BDNF
Information below summarizes published pre-clinical and clinical research. It is provided for educational purposes for qualified researchers and is not medical advice, a treatment recommendation, or a claim of efficacy. Products are sold for research use only.
